11 Publikationen

Alle markieren

[11]
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2940382 OA
Borbély AN, Thoreau F, Figueras Agustí E, et al. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Chemistry. 2020;26(12):2602-2605.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[10]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936495 OA
Borbély AN, Figueras Agustí E, Martins A, et al. Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. ChemistryOpen. 2019;8(6):737-742.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[9]
2019 | Dissertation | PUB-ID: 2937966
Borbély AN. Conjugates of Cryptophycin and RGD Peptides for Targeted Cancer Therapy. Bielefeld: Universität Bielefeld; 2019.
PUB
 
[8]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935650 OA
Figueras Agustí E, Martins A, Borbély AN, et al. Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics. 2019;11(5): 220.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[7]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934762 OA
Borbély AN, Figueras Agustí E, Martins A, et al. Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics. 2019;11(4): 151.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[6]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2944897
Cazzamalli S, Figueras Agustí E, Pethő L, et al. Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega. 2018;3(12):16743-16743.
PUB | DOI
 
[5]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2920953
Figueras Agustí E, Borbély AN, Ismail M, Frese M, Sewald N. Novel unit B cryptophycin analogues as payloads for targeted therapy. BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY. 2018;14:1281-1286.
PUB | DOI | WoS | PubMed | Europe PMC
 
[4]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2932984
Cazzamalli S, Figueras Agustí E, Petho L, et al. In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS OMEGA. 2018;3(11):14726-14731.
PUB | DOI | WoS | PubMed | Europe PMC
 
[3]
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931993
Borbély AN, Figueras Agustí E, Martins A, et al. Novel Cryptophycin-based Conjugates for Tumor Targeting. In: JOURNAL OF PEPTIDE SCIENCE. Vol 24. Hoboken: Wiley; 2018: S59.
PUB | WoS
 
[2]
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931996
Figueras Agustí E, Martins A, Borbély AN, et al. Tumor Targeting of Cryptophycin based Conjugates Using Octreotide as Delivery Vehicle. In: JOURNAL OF PEPTIDE SCIENCE. Vol 24. Hoboken: Wiley; 2018: S166.
PUB | WoS
 
[1]
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916981 OA
Weiss C, Figueras Agustí E, Borbély AN, Sewald N. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting. Journal of Peptide Science. 2017;23(7-8):514-531.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 

Suche

Publikationen filtern

Darstellung / Sortierung

Zitationsstil: ama

Export / Einbettung

11 Publikationen

Alle markieren

[11]
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2940382 OA
Borbély AN, Thoreau F, Figueras Agustí E, et al. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Chemistry. 2020;26(12):2602-2605.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[10]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936495 OA
Borbély AN, Figueras Agustí E, Martins A, et al. Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. ChemistryOpen. 2019;8(6):737-742.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[9]
2019 | Dissertation | PUB-ID: 2937966
Borbély AN. Conjugates of Cryptophycin and RGD Peptides for Targeted Cancer Therapy. Bielefeld: Universität Bielefeld; 2019.
PUB
 
[8]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935650 OA
Figueras Agustí E, Martins A, Borbély AN, et al. Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics. 2019;11(5): 220.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[7]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934762 OA
Borbély AN, Figueras Agustí E, Martins A, et al. Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics. 2019;11(4): 151.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[6]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2944897
Cazzamalli S, Figueras Agustí E, Pethő L, et al. Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega. 2018;3(12):16743-16743.
PUB | DOI
 
[5]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2920953
Figueras Agustí E, Borbély AN, Ismail M, Frese M, Sewald N. Novel unit B cryptophycin analogues as payloads for targeted therapy. BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY. 2018;14:1281-1286.
PUB | DOI | WoS | PubMed | Europe PMC
 
[4]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2932984
Cazzamalli S, Figueras Agustí E, Petho L, et al. In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS OMEGA. 2018;3(11):14726-14731.
PUB | DOI | WoS | PubMed | Europe PMC
 
[3]
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931993
Borbély AN, Figueras Agustí E, Martins A, et al. Novel Cryptophycin-based Conjugates for Tumor Targeting. In: JOURNAL OF PEPTIDE SCIENCE. Vol 24. Hoboken: Wiley; 2018: S59.
PUB | WoS
 
[2]
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931996
Figueras Agustí E, Martins A, Borbély AN, et al. Tumor Targeting of Cryptophycin based Conjugates Using Octreotide as Delivery Vehicle. In: JOURNAL OF PEPTIDE SCIENCE. Vol 24. Hoboken: Wiley; 2018: S166.
PUB | WoS
 
[1]
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916981 OA
Weiss C, Figueras Agustí E, Borbély AN, Sewald N. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting. Journal of Peptide Science. 2017;23(7-8):514-531.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 

Suche

Publikationen filtern

Darstellung / Sortierung

Zitationsstil: ama

Export / Einbettung